IL SB3545

Requires individual and group accident and health insurance policies amended, delivered, issued, or renewed after the effective date to provide coverage for anti-epileptic drugs with no waiting periods, deductibles, coinsurance, copayments, or cost-sharing limitations greater than other covered drugs.

Prohibits pharmacists from substituting or interchanging anti-epileptic drugs or formulations for epilepsy treatment; requires prescribing physicians to document that the specific anti-epileptic drug or formulation is clinically necessary for the patient's optimal care.

Amends the Managed Care Reform and Patient Rights Act to prohibit substitution of anti-seizure prescription drugs with generic drugs under pharmacy practice provisions allowing therapeutic equivalent substitutions.

Removes previous notification and consent requirements between pharmacists, physicians, and patients when generic anti-epileptic drugs were substituted for brand-name versions.

Defines key terms: "anti-epileptic drug" as drugs prescribed for epilepsy treatment or seizure prevention, "epilepsy" as a neurological condition with recurrent seizures, and "seizure" as brief electrical disturbances in brain activity.